- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Konica lands generic x-ray contrast agent
Konica Corp. has signed an agreement with Fuji Pharmaceuticalfor Japanese sales of Oiparomin, a generic x-ray contrast agent,according to Japan's Comline Business Data. The agent was approvedby the country's Ministry of Health and Welfare in March and
Konica Corp. has signed an agreement with Fuji Pharmaceuticalfor Japanese sales of Oiparomin, a generic x-ray contrast agent,according to Japan's Comline Business Data. The agent was approvedby the country's Ministry of Health and Welfare in March and aproduct launch will occur as soon as final pricing approval isreceived in July, Comline said.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
